What distinguishes PKM2 from other isoforms’ ability to switch between a highly active tetrameric form and a less active dimeric form that supports oncogenic processes by slowing down glycolysis to accumulate precursor biomolecules necessary for cancer biosynthesis pathways [44,45]. The gene discussed is PKM; the disease is cancer.